RETA Annual Working Capital
$338.81 M
-$203.67 M-37.54%
31 December 2022
Summary:
As of February 5, 2025, RETA annual working capital is $338.81 million, with the most recent change of -$203.67 million (-37.54%) on December 31, 2022. During the last 3 years, it has fallen by -$138.45 million (-29.01%).RETA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RETA Quarterly Working Capital
$276.76 M
-$1.19 M-0.43%
30 June 2023
Summary:
As of February 5, 2025, RETA quarterly working capital is $276.76 million, with the most recent change of -$1.19 million (-0.43%) on June 30, 2023. Over the past year, it has dropped by -$168.13 million (-37.79%).RETA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RETA Working Capital Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -37.5% | -37.8% |
3 y3 years | -29.0% | -53.4% |
5 y5 years | +296.3% | +137.2% |
RETA Working Capital High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time | -53.5% | -62.0% |
Reata Pharmaceuticals Working Capital History
Date | Annual | Quarterly |
---|---|---|
June 2023 | - | $276.76 M(-0.4%) |
Mar 2023 | - | $277.94 M(-18.0%) |
Dec 2022 | $338.81 M(-37.5%) | $338.81 M(-14.1%) |
Sept 2022 | - | $394.39 M(-11.3%) |
June 2022 | - | $444.88 M(-9.9%) |
Mar 2022 | - | $493.72 M(-9.0%) |
Dec 2021 | $542.48 M(-25.5%) | $542.48 M(-9.6%) |
Sept 2021 | - | $600.38 M(-7.1%) |
June 2021 | - | $646.58 M(-6.5%) |
Mar 2021 | - | $691.16 M(-5.1%) |
Dec 2020 | $728.14 M(+52.6%) | $728.14 M(+30.0%) |
Sept 2020 | - | $560.27 M(-5.6%) |
June 2020 | - | $593.28 M(+31.5%) |
Mar 2020 | - | $451.02 M(-5.5%) |
Dec 2019 | $477.26 M | $477.26 M(+177.5%) |
Sept 2019 | - | $171.97 M(-21.7%) |
June 2019 | - | $219.50 M(-14.3%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $256.27 M(-10.5%) |
Dec 2018 | $286.35 M(+234.9%) | $286.35 M(-9.7%) |
Sept 2018 | - | $316.95 M(+171.6%) |
June 2018 | - | $116.68 M(+39.9%) |
Mar 2018 | - | $83.38 M(-2.5%) |
Dec 2017 | $85.49 M(+209.2%) | $85.49 M(-21.0%) |
Sept 2017 | - | $108.24 M(+516.9%) |
June 2017 | - | $17.55 M(-49.2%) |
Mar 2017 | - | $34.52 M(+24.9%) |
Dec 2016 | $27.65 M(+68.2%) | $27.65 M(-30.6%) |
Sept 2016 | - | $39.85 M(-24.7%) |
June 2016 | - | $52.92 M(+1104.7%) |
Mar 2016 | - | $4.39 M(-73.3%) |
Dec 2015 | $16.44 M(-66.2%) | $16.44 M(-36.2%) |
Sept 2015 | - | $25.75 M(-47.0%) |
Dec 2014 | $48.60 M(-37.1%) | $48.60 M |
Dec 2013 | $77.25 M | - |
FAQ
- What is Reata Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Reata Pharmaceuticals?
- What is Reata Pharmaceuticals annual working capital year-on-year change?
- What is Reata Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Reata Pharmaceuticals?
- What is Reata Pharmaceuticals quarterly working capital year-on-year change?
What is Reata Pharmaceuticals annual working capital?
The current annual working capital of RETA is $338.81 M
What is the all time high annual working capital for Reata Pharmaceuticals?
Reata Pharmaceuticals all-time high annual working capital is $728.14 M
What is Reata Pharmaceuticals annual working capital year-on-year change?
Over the past year, RETA annual working capital has changed by -$203.67 M (-37.54%)
What is Reata Pharmaceuticals quarterly working capital?
The current quarterly working capital of RETA is $276.76 M
What is the all time high quarterly working capital for Reata Pharmaceuticals?
Reata Pharmaceuticals all-time high quarterly working capital is $728.14 M
What is Reata Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, RETA quarterly working capital has changed by -$168.13 M (-37.79%)